Bergqvist D - Search Results

1

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE). Cohen AT, et al. Among authors: bergqvist d. Thromb Haemost. 2007 Oct;98(4):756-64. Thromb Haemost. 2007. PMID: 17938798

2

Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.

Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators. Bergqvist D, et al. Thromb Haemost. 2012 Feb;107(2):270-9. doi: 10.1160/TH11-07-0463. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186708

3

Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.

Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators. Bergqvist D, et al. Thromb Haemost. 2012 Feb;107(2):280-7. doi: 10.1160/TH11-07-0464. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186771

4

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.

Francis CW, Kessler CM, Goldhaber SZ, Kovacs MJ, Monreal M, Huisman MV, Bergqvist D, Turpie AG, Ortel TL, Spyropoulos AC, Pabinger I, Kakkar AK. Francis CW, et al. Among authors: bergqvist d. J Thromb Haemost. 2015 Jun;13(6):1028-35. doi: 10.1111/jth.12923. Epub 2015 May 10. J Thromb Haemost. 2015. PMID: 25827941 Free article. Clinical Trial.

5

Venous thromboembolism and cancer.

Bergqvist D, Caprini JA, Dotsenko O, Kakkar AK, Mishra RG, Wakefield TW. Bergqvist D, et al. Curr Probl Surg. 2007 Mar;44(3):157-216. doi: 10.1067/j.cpsurg.2007.01.004. Curr Probl Surg. 2007. PMID: 17437761 Review. No abstract available.

6

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F; ENOXACAN II Investigators. Bergqvist D, et al. N Engl J Med. 2002 Mar 28;346(13):975-80. doi: 10.1056/NEJMoa012385. N Engl J Med. 2002. PMID: 11919306 Free article. Clinical Trial.

7

Prevention of venous thromboembolism.

Geerts W, Ray JG, Colwell CW, Bergqvist D, Pineo GF, Lassen MR, Heit JA. Geerts W, et al. Among authors: bergqvist d. Chest. 2005 Nov;128(5):3775-6. doi: 10.1378/chest.128.5.3775. Chest. 2005. PMID: 16304350 No abstract available.

8

Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies.

Eliasson A, Bergqvist D, Björck M, Acosta S, Sternby NH, Ogren M. Eliasson A, et al. Among authors: bergqvist d. J Thromb Haemost. 2006 Sep;4(9):1897-902. doi: 10.1111/j.1538-7836.2006.02152.x. Epub 2006 Aug 1. J Thromb Haemost. 2006. PMID: 16881933 Free article.

9

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.

Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M; PEGASUS investigators. Agnelli G, et al. Among authors: bergqvist d. Br J Surg. 2005 Oct;92(10):1212-20. doi: 10.1002/bjs.5154. Br J Surg. 2005. PMID: 16175516 Clinical Trial.

10

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran.

Agnelli G, Eriksson BI, Cohen AT, Bergqvist D, Dahl OE, Lassen MR, Mouret P, Rosencher N, Andersson M, Bylock A, Jensen E, Boberg B; EXTEND Study Group. Agnelli G, et al. Among authors: bergqvist d. Thromb Res. 2009;123(3):488-97. doi: 10.1016/j.thromres.2008.02.017. Epub 2008 May 15. Thromb Res. 2009. PMID: 18485453 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

881 results

Search Page